¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ - Á¦Ç°º°, ¼ºñ½ºº°, À§»óº°, Áö¿ªº° ½ÃÀå ¿¹Ãø(2024-2032³â)
Clinical Trial Biorepository & Archiving Solutions Market Size, Share, Trends, Industry Analysis Report: By Product, By Service, By Phase, and By Region - Market Forecast, 2024-2032
»óǰÄÚµå
:
1566345
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2024³â 09¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 116 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 80¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀº ÀÓ»ó½ÃÇè Áß¿¡ ¼öÁýµÈ »ý¹°ÇÐÀû »ùÇà ¹× µ¥ÀÌÅÍÀÇ º¸°ü, °ü¸®, º¸Á¸À» À§ÇÑ ¼ºñ½º ¹× ±â¼úÀ» Á¦°øÇÏ´Â ÀÇ·á ¹× »ý¸í°úÇÐ »ê¾÷ ºÐ¾ß¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â Ç÷¾×, Á¶Á÷, DNA ¹× ±âŸ »ý¹°ÇÐÀû ¹°Áú°ú °°Àº »ùÇÃÀ» ó¸®Çϰí ÇâÈÄ ¿¬±¸ ¹× ºÐ¼®À» À§ÇØ ¿ÏÀü¼º°ú °¡¿ë¼ºÀ» º¸ÀåÇϱâ À§ÇØ ¼³°èµÈ ´Ù¾çÇÑ ¼Ö·ç¼ÇÀÌ Æ÷ÇԵ˴ϴÙ. ÀǾàǰ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í »ý¹°ÇÐÀû ½Ã·áÀÇ È¿À²ÀûÀÎ °ü¸®¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀÌ À̾îÁö°í ÀÖ½À´Ï´Ù. ±âŸ ¼¼°è ÀÓ»ó½ÃÇè Áõ°¡, ¹ÙÀÌ¿À¹ðÅ· ±â¼ú Áøº¸, µ¥ÀÌÅÍ ¹«°á¼º ¹× »ùÇà º¸Á¸¿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°Ç Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °æ»ç Áõ°¡, À¯Àüü ¿¬±¸¿¡ ´ëÇÑ °ü½É Áõ°¡, »ùÇà ÃßÀû ¹× ºÐ¼®À» À§ÇÑ AI¿Í ÀÚµ¿ÈÀÇ ÅëÇÕÀº ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå¿¡ ¾öû³ ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. ½ÃÀå¿¡¼´Â Áß¾Ó ÁýÁᫎ ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮¿Í Ŭ¶ó¿ìµå ±â¹Ý ¾ÆÄ«ÀÌºê ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀÌ ÁøÇàµÇ°í ÀÖ¾î Á¢±Ù¼º°ú Çù¾÷ÀÌ °ÈµÇ°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ÀÓ»ó½ÃÇèÀÇ º¹À⼺°ú ´Ù¾çÇÑ ¿¬±¸°³¹ß°ú Ä¡·á°³¹ßÀ» Áö¿øÇÏ´Â °ß°íÇÑ ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ÀÎÇÁ¶óÀÇ Çʿ伺À¸·Î ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
Á¦Ç°º°·Î, ÀÓ»ó Á¦Ç° ºÐ¾ß´Â ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÀÓ»ó½ÃÇè °Ç¼ö Áõ°¡¿Í ÀǾàǰ °³¹ßÀÇ ´Ù¾çÇÑ ´Ü°è¿¡¼ÀÇ °íǰÁú »ùÇà °ü¸®¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.
¼ºñ½ºº°·Î´Â »ý¹° ½Ã·áÀÇ º¸°ü ¹× °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¼ºñ½º°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.
ÆäÀÌÁ·Î´Â ÆäÀÌÁî III°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸À̰í ÀÖÁö¸¸, ÀÌ´Â À¯¸ÁÇÑ ½Å¾à È常¦ ±â¾÷ÀÌ ½ÃÀå ½ÂÀΰú »ó¾÷ȸ¦ ÇâÇØ ÁøÇàÇÏ´Â °¡¿îµ¥, ÀÌ ´Ü°è¿¡¼ÀÇ ÀÓ»ó½ÃÇè ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀ» ¹Ý¿µÇÕ´Ï´Ù.
ºÏ¹Ì´Â ±¤¹üÀ§ÇÑ ÀÓ»ó ¿¬±¸ ÀÎÇÁ¶ó¿Í ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÅëÇØ ¼¼°è ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÅÈï±¹¿¡¼ÀÇ ÀÓ»ó½ÃÇè ±ÞÁõ°ú ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ÅõÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå ¼ºÀåÇϰí ÀÖ´Â Áö¿ªÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ¼¼°è ½ÃÀå ºÐ¼®
½ÃÀå ÇöȲ
ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀΰú ±âȸ
ÀÚµ¿ »ùÇà °ü¸®ÀÇ È®´ë°¡ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎ
µ¥ÀÌÅÍ ºÐ¼®°ú ÅëÇÕ¿¡ ´ëÇÑ ÁÖ¸ñÀÇ °íÁ¶°¡ ½ÃÀåÀ» °ßÀÎ
¾ïÁ¦¿äÀΰú °úÁ¦
³ôÀº ¿î¿ë ºñ¿ëÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇϰí ÀÖ´Ù
PESTEL ºÐ¼®
ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀÇ ¿ëµµ µ¿Çâ
¹ë·ùüÀÎ ºÐ¼®
COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç°º°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
ÀüÀÓ»ó Á¦Ç°
ÀÓ»ó Á¦Ç°
Á¦6Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : ¼ºñ½ºº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¼ºñ½º
¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ¼ºñ½º
Á¦7Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : ´Ü°èº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
ÀüÀÓ»ó
ÆäÀÌÁî I
ÆäÀÌÁî II
ÆäÀÌÁî III
ÆäÀÌÁî IV
Á¦8Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå :Áö¿ª
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå Æò°¡:Áö¿ª, 2019-2032³â
ºÏ¹Ì
ºÏ¹Ì : Á¦Ç°º°, 2019-2032³â
ºÏ¹Ì : ¼ºñ½ºº°, 2019-2032³â
ºÏ¹Ì : ÆäÀÌÁ, 2019-2032³â
¹Ì±¹
ij³ª´Ù
À¯·´
À¯·´ : Á¦Ç°º°, 2019-2032³â
À¯·´ : ¼ºñ½ºº°, 2019-2032³â
À¯·´ : ÆäÀÌÁ, 2019-2032³â
¿µ±¹
ÇÁ¶û½º
µ¶ÀÏ
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
³×´ú¶õµå
·¯½Ã¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾ç: Á¦Ç°º°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç: ¼ºñ½ºº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç: À§»óº°, 2019-2032³â
Áß±¹
Àεµ
¸»·¹À̽þÆ
ÀϺ»
Àεµ³×½Ã¾Æ
Çѱ¹
È£ÁÖ
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«: Á¦Ç°º°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¼ºñ½ºº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÆäÀÌÁ, 2019-2032³â
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
À̽º¶ó¿¤
³²¾ÆÇÁ¸®Ä«
±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç°º°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : ¼ºñ½ºº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : ÆäÀÌÁ, 2019-2032³â
¸ß½ÃÄÚ
ºê¶óÁú
¾Æ¸£ÇîÆ¼³ª
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
È®´ë¿Í Àμö ºÐ¼®
Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
Thermo Fisher Scientific
LabCorp
BioStorage Technologies
Brooks Life Sciences
QIAGEN
VWR International(part of Avantor)
Sartorius AG
Hamilton Company
NMDP BioTherapies
Precision Biobank
CryoPort
BioBanking Solutions
Celerion
STC Biologics
Pfizer(biorepository and archiving division)
Novartis(biorepository and archiving division)
JHS
¿µ¹® ¸ñÂ÷
The global clinical trial biorepository & archiving solutions market size is expected to reach USD 8.09 billion by 2032, according to a new study by Polaris Market Research. The report "Clinical Trial Biorepository & Archiving Solutions Market Size, Share, Trends, Industry Analysis Report: By Product (Preclinical Products and Clinical Products), By Service, By Phase, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The clinical trial biorepository & archiving solutions market refers to the sector of the healthcare and life sciences industry that provides services and technologies for the storage, management, and preservation of biological samples and data collected during clinical trials. This market includes a range of solutions designed to handle samples such as blood, tissue, DNA, and other biological materials, ensuring their integrity and availability for future research and analysis. Increasing investments in drug development and growing need for efficient management of biological samples drive the clinical trial biorepository & archiving solutions market growth. Other factors such as a rise in clinical trials globally, advancements in biobanking technologies, and increase in regulatory requirements for data integrity and sample storage propel the market growth.
Rising inclination toward personalized medicine, increasing focus on genomic research, and the integration of AI and automation for sample tracking and analysis would provide vast opportunities for the market in the coming years. Emerging in the market are a shift toward centralized biorepositories and cloud-based archiving solutions, enhancing accessibility and collaboration. Overall, the market is expected to grow significantly, driven by the increasing complexity of clinical trials and the need for robust biorepository infrastructure to support diverse research and therapeutic developments.
Clinical Trial Biorepository & Archiving Solutions Market Report Highlights
By product, the clinical products segment dominates the clinical trial biorepository & archiving solutions market, driven by the increasing number of clinical trials and the rising need for high-quality sample management across various stages of drug development.
The biorepository services dominate the market, based on service type, due to their critical role in the storage and management of biological samples, essential for the growing number of clinical and research studies requiring extensive sample archiving.
In terms of phase, the phase III segment is witnessing the highest growth rate, reflecting the increasing number of trials in this phase as companies advance promising drug candidates toward market approval and commercialization.
North America dominates the global clinical trial biorepository & archiving solutions market, owing to its extensive clinical research infrastructure and investments in biorepository solutions. However, Asia Pacific is the highest growing region, driven by a surge in clinical trials and increase in biorepository investments in emerging economies.
Polaris Market Research has segmented the clinical trial biorepository & archiving solutions market report on the basis of product, service, phase, and region.
Clinical Trial Biorepository & Archiving Solutions, Product Outlook (Revenue - USD Billion, 2019-2032)
Preclinical Products
Clinical Products
Clinical Trial Biorepository & Archiving Solutions, Service Outlook (Revenue - USD Billion, 2019-2032)
Biorepository Services
Archiving Solution Services
Clinical Trial Biorepository & Archiving Solutions, Phase Outlook (Revenue - USD Billion, 2019-2032)
Preclinical
Phase I
Phase II
Phase III
Phase IV
Clinical Trial Biorepository & Archiving Solutions, Regional Outlook (Revenue - USD Billion, 2019-2032)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Clinical Trial Biorepository & Archiving Solutions Market Insights
4.1. Clinical Trial Biorepository & Archiving Solutions Market - Market Snapshot
4.2. Clinical Trial Biorepository & Archiving Solutions Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Expansion of Automated Sample Management is Driving the Market Growth
4.2.1.2. Growing Focus On Data Analytics and Integration Propels the Market
4.2.2. Restraints and Challenges
4.2.2.1. High Operational Costs is Hindering the Market Growth
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Clinical Trial Biorepository & Archiving Solutions Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Clinical Trial Biorepository & Archiving Solutions Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
5.3. Preclinical Products
5.3.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Preclinical Products, by Region, 2019-2032 (USD Billion)
5.4. Clinical Products
5.4.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Clinical Products, by Region, 2019-2032 (USD Billion)
6. Global Clinical Trial Biorepository & Archiving Solutions Market, by Service Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
6.3. Biorepository Services
6.3.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Biorepository Services, by Region, 2019-2032 (USD Billion)
6.4. Archiving Solution Services
6.4.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Archiving Solution Services, by Region, 2019-2032 (USD Billion)
7. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase
7.1. Key Findings
7.2. Introduction
7.2.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
7.3. Preclinical
7.3.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Preclinical, by Region, 2019-2032 (USD Billion)
7.4. Phase I
7.4.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase I, by Region, 2019-2032 (USD Billion)
7.5. Phase II
7.5.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase II, by Region, 2019-2032 (USD Billion)
7.6. Phase III
7.6.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase III, by Region, 2019-2032 (USD Billion)
7.7. Phase IV
7.7.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase IV, by Region, 2019-2032 (USD Billion)
8. Global Clinical Trial Biorepository & Archiving Solutions Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Clinical Trial Biorepository & Archiving Solutions Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Clinical Trial Biorepository & Archiving Solutions Market - North America
8.3.1. North America: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.3.2. North America: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.3.3. North America: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.3.4. Clinical Trial Biorepository & Archiving Solutions Market - U.S.
8.3.4.1. U.S.: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.3.4.2. U.S.: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.3.4.3. U.S.: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.3.5. Clinical Trial Biorepository & Archiving Solutions Market - Canada
8.3.5.1. Canada: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.3.5.2. Canada: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.3.5.3. Canada: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4. Clinical Trial Biorepository & Archiving Solutions Market - Europe
8.4.1. Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.2. Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.3. Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.4. Clinical Trial Biorepository & Archiving Solutions Market - UK
8.4.4.1. UK: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.4.2. UK: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.4.3. UK: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.5. Clinical Trial Biorepository & Archiving Solutions Market - France
8.4.5.1. France: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.5.2. France: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.5.3. France: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.6. Clinical Trial Biorepository & Archiving Solutions Market - Germany
8.4.6.1. Germany: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.6.2. Germany: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.6.3. Germany: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.7. Clinical Trial Biorepository & Archiving Solutions Market - Italy
8.4.7.1. Italy: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.7.2. Italy: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.7.3. Italy: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.8. Clinical Trial Biorepository & Archiving Solutions Market - Spain
8.4.8.1. Spain: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.8.2. Spain: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.8.3. Spain: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.9. Clinical Trial Biorepository & Archiving Solutions Market - Netherlands
8.4.9.1. Netherlands: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.9.2. Netherlands: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.9.3. Netherlands: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.10. Clinical Trial Biorepository & Archiving Solutions Market - Russia
8.4.10.1. Russia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.10.2. Russia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.10.3. Russia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.11. Clinical Trial Biorepository & Archiving Solutions Market - Rest of Europe
8.4.11.1. Rest of Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.11.2. Rest of Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.11.3. Rest of Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5. Clinical Trial Biorepository & Archiving Solutions Market - Asia Pacific
8.5.1. Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.2. Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.3. Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.4. Clinical Trial Biorepository & Archiving Solutions Market - China
8.5.4.1. China: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.4.2. China: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.4.3. China: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.5. Clinical Trial Biorepository & Archiving Solutions Market - India
8.5.5.1. India: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.5.2. India: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.5.3. India: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.6. Clinical Trial Biorepository & Archiving Solutions Market - Malaysia
8.5.6.1. Malaysia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.6.2. Malaysia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.6.3. Malaysia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.7. Clinical Trial Biorepository & Archiving Solutions Market - Japan
8.5.7.1. Japan: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.7.2. Japan: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.7.3. Japan: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.8. Clinical Trial Biorepository & Archiving Solutions Market - Indonesia
8.5.8.1. Indonesia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.8.2. Indonesia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.8.3. Indonesia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.9. Clinical Trial Biorepository & Archiving Solutions Market - South Korea
8.5.9.1. South Korea: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.9.2. South Korea: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.9.3. South Korea: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.10. Clinical Trial Biorepository & Archiving Solutions Market - Australia
8.5.10.1. Australia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.10.2. Australia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.10.3. Australia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.11. Clinical Trial Biorepository & Archiving Solutions Market - Rest of Asia Pacific
8.5.11.1. Rest of Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.11.2. Rest of Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.11.3. Rest of Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6. Clinical Trial Biorepository & Archiving Solutions Market - Middle East & Africa
8.6.1. Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.2. Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.3. Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.4. Clinical Trial Biorepository & Archiving Solutions Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.4.2. Saudi Arabia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.4.3. Saudi Arabia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.5. Clinical Trial Biorepository & Archiving Solutions Market - UAE
8.6.5.1. UAE: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.5.2. UAE: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.5.3. UAE: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.6. Clinical Trial Biorepository & Archiving Solutions Market - Israel
8.6.6.1. Israel: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.6.2. Israel: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.6.3. Israel: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.7. Clinical Trial Biorepository & Archiving Solutions Market - South Africa
8.6.7.1. South Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.7.2. South Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.7.3. South Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.8. Clinical Trial Biorepository & Archiving Solutions Market - Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.8.2. Rest of Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.8.3. Rest of Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7. Clinical Trial Biorepository & Archiving Solutions Market - Latin America
8.7.1. Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.2. Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.3. Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7.4. Clinical Trial Biorepository & Archiving Solutions Market - Mexico
8.7.4.1. Mexico: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.4.2. Mexico: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.4.3. Mexico: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7.5. Clinical Trial Biorepository & Archiving Solutions Market - Brazil
8.7.5.1. Brazil: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.5.2. Brazil: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.5.3. Brazil: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7.6. Clinical Trial Biorepository & Archiving Solutions Market - Argentina
8.7.6.1. Argentina: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.6.2. Argentina: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.6.3. Argentina: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7.7. Clinical Trial Biorepository & Archiving Solutions Market - Rest of Latin America
8.7.7.1. Rest of Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.7.2. Rest of Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.7.3. Rest of Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Thermo Fisher Scientific
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. LabCorp
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. BioStorage Technologies
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Brooks Life Sciences
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. QIAGEN
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. VWR International (part of Avantor)
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Sartorius AG
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Hamilton Company
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. NMDP BioTherapies
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Precision Biobank
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. CryoPort
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. BioBanking Solutions
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Celerion
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. STC Biologics
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. Pfizer (biorepository and archiving division)
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development
10.16. Novartis (biorepository and archiving division)
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Recent Development
°ü·ÃÀÚ·á